CUA Highlights of GU ASCO 2022 - Kidney Cancer Session - French

Canadian Urological Association (CUA)

English - February 22, 2022 05:00 - 49 minutes - 113 MB
Medicine Health & Fitness Science Life Sciences medicine urologic urology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: CUA Practice Changing Publications (PCP) - Endourology (Surgical Management of BPH)

Next Episode: CUA Q & A Series | Bone Health Management in Prostate Cancer - David Kendler

Disclosures:

Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position

Christian Kollmannsberger
Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer
Honoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, Bayer
Scientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, BMS, Janssen, Bayer, Merck